Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

ANDREW S ALLEGRETTI

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1427378991
CMS profile
660347
Location
BOSTON, MA

General Payments · PY2019–2025

$138,940.25

  • Reported across 60 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$34,404.98

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $34,400.00 11
Education $4.98 3

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $34,400.00 11
Retrophin, Inc. $4.98 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $19.84 1
PY2020 $7,425.00 2
PY2021 $17,232.61 9
PY2022 $19,571.37 8
PY2023 $17,700.00 5
PY2024 $42,586.45 21
PY2025 $34,404.98 14

Payment records · PY2025 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $3,000.00 01/15/2025 Consulting Fee Undisputed 06/30/2026 1207045037 CMS
AstraZeneca Pharmaceuticals LP $3,300.00 01/15/2025 Consulting Fee Undisputed 06/30/2026 1207273786 CMS
AstraZeneca Pharmaceuticals LP $3,750.00 02/15/2025 Consulting Fee Undisputed 06/30/2026 1206663296 CMS
AstraZeneca Pharmaceuticals LP $2,550.00 03/15/2025 Consulting Fee Undisputed 06/30/2026 1206532942 CMS
AstraZeneca Pharmaceuticals LP $3,150.00 04/15/2025 Consulting Fee Undisputed 06/30/2026 1207216226 CMS
AstraZeneca Pharmaceuticals LP $3,000.00 05/15/2025 Consulting Fee Undisputed 06/30/2026 1206791679 CMS
AstraZeneca Pharmaceuticals LP $2,450.00 07/15/2025 Consulting Fee Undisputed 06/30/2026 1206773760 CMS
AstraZeneca Pharmaceuticals LP $2,550.00 07/15/2025 Consulting Fee Undisputed 06/30/2026 1206820401 CMS
AstraZeneca Pharmaceuticals LP $3,750.00 10/15/2025 Consulting Fee Undisputed 06/30/2026 1206286694 CMS
AstraZeneca Pharmaceuticals LP $3,300.00 10/15/2025 Consulting Fee Undisputed 06/30/2026 1207195159 CMS
AstraZeneca Pharmaceuticals LP $3,600.00 12/15/2025 Consulting Fee Undisputed 06/30/2026 1207220621 CMS
Travere Therapeutics, Inc. $1.66 08/18/2025 Education Undisputed 06/30/2026 1244428837 CMS
Travere Therapeutics, Inc. $1.66 10/13/2025 Education Undisputed 06/30/2026 1244428839 CMS
Travere Therapeutics, Inc. $1.66 12/08/2025 Education Undisputed 06/30/2026 1244428841 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.